Apoptosis induction by miR-19b inhibition: does it show therapeutic potential for leukemia?

Nucleosides Nucleotides Nucleic Acids. 2020;39(7):1073-1081. doi: 10.1080/15257770.2020.1755042. Epub 2020 Apr 28.

Abstract

High levels of miR-19 play an important role in malignant diseases of the hematopoietic system. Therefore the treatment with corresponding microRNA antagonists seems to be an interesting therapeutic approach. We found a significant increase of apoptosis in Jurkat cells which were transfected with a miR-19b inhibitor. The rise of apoptosis in transfected human monocuclear cells (MNCs) was significant as well, but the unspecific miRNA control induced apoptosis in MNCs to a similar extend. A closer look at the MNC subpopulations revealed higher specific apoptosis in B cells whereas T cell apoptosis was lower and induced by unspecific miRNA interference.

Keywords: MicroRNA; leukemia; lymphoma; miR-19; mir-17-92.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Humans
  • Leukemia / drug therapy*
  • Leukemia / metabolism
  • Leukemia / pathology
  • Lipids / pharmacology*
  • Lymphoma / drug therapy*
  • Lymphoma / metabolism
  • Lymphoma / pathology
  • MicroRNAs / antagonists & inhibitors*
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Lipids
  • Lipofectamine
  • MIRN19 microRNA, human
  • MicroRNAs